Key result
Left ventricular global longitudinal strain >-12.65% independently predicted adverse cardiac outcomes in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Why the study?
The study sought to investigate left ventricular global myocardial strain and involvement characteristics in patients with ARVD/C and evaluate their predictive value for adverse cardiac events.
Does left ventricular global myocardial strain assessed by CMR feature tracking predict adverse cardiac events in patients with ARVD/C?
Observational (n=94)
No
Does left ventricular global myocardial strain assessed by CMR feature tracking predict adverse cardiac events in patients with ARVD/C?
Left ventricular global longitudinal strain assessed by CMR feature tracking is significantly impaired in ARVD/C patients and serves as an independent predictor of adverse cardiac events.
Answers are grounded in this paper and cite their sources.
May refine ARVD/C risk stratification; hypothesis-generating for CMR feature tracking validation in larger cohorts.
The aim of this study was to investigate left ventricular (LV) global myocardial strain and LV involvement characteristics in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and to evaluate their predictive value of adverse cardiac events. Sixty consecutive ARVD/C patients with a definite diagnosis of ARVD/C who underwent CMR examination and thirty-four healthy controls were enrolled retrospectively. The CMR images were analyzed for LV myocardial strain and the presence of LV involvement. The endpoint was defined as a composite of sustained ventricular tachycardia or fibrillation, cardiac death, resuscitated cardiac arrest, heart transplantation, and appropriate implantable cardioverter-defibrillator shock. LV global longitudinal (GLS), circumferential (GCS), and radial strain (GRS) were significantly impaired in ARVC/D patients compared to healthy controls (GLS: -13.89 ± 3.26% vs. -16.68 ± 2.74%, GCS: -15.65 ± 3.40% vs. -19.20 ± 2.23%, GRS: 34.57 ± 11.98% vs. 49.92 ± 12.59%; P < 0.001 for all). Even in ARVC/D patients with preserved LVEF, LV GLS, GCS and GRS were also significantly reduced than in controls. During a mean follow-up period of 4.10 ± 1.77 years, the endpoint was reached in 17 patients. LV GLS >-12.65% (HR, 3.58; 95%CI, 1.14 to 11.25; p = 0.029) and history of syncope (HR, 4.99; 95%CI, 1.88 to 13.24; p = 0.001) were the only independent predictors of cardiac outcomes. The LV myocardial deformation derived from FT CMR was significantly impaired in ARVD/C patients, and this alteration can occur before the impairment of LVEF. LV GLS >-12.65% and history of syncope were the only independent prognostic markers of adverse cardiac outcomes.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2019) conducted an observational in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) (n=94). Left ventricular global longitudinal strain (LV GLS) > -12.65% vs. LV GLS ≤ -12.65% was evaluated on Composite of sustained ventricular tachycardia or fibrillation, cardiac death, resuscitated cardiac arrest, heart transplantation, and appropriate implantable cardioverter-defibrillator shock (HR 3.58, 95% CI 1.14 to 11.25, p=0.029). Left ventricular global longitudinal strain >-12.65% independently predicted adverse cardiac outcomes in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: